Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Statement of Cash Flows [Abstract]
Net income	$ (136,752,136)	$ 11,590,395
Adjustments to reconcile net income to net cash provided by (used in) operating activities
Issuance of common stock and stock options for compensation		130,000
Depreciation and amortization	4,698,482	4,920,779
Provision for losses on accounts receivable	118,362,520	9,906,681
Gain (Loss) on disposal of property, plant and equipment	38,223	4,525
Amortization of debt discount	41,707	411,743
Goodwill impairment	607,677
Inventories impairment	39,643,198
Change in fair value of derivative liability	(17,736)	(45,917)
Changes in operating assets
Accounts receivable	(82,782,877)	13,277,343
Amount due from related parties	(66)	228,629
Other current assets	(873,111)	63,973
Inventories	19,170,514	(110,880,651)
Advances to suppliers	(33,450,217)	731,013
Other assets	1,889,043	1,977,942
Changes in operating liabilities
Accounts payable	(759,998)	(7,209,214)
Customer deposits	1,016,311	(481,166)
Tax payables	355,567	1,448,673
Accrued expenses and other payables	2,590,822	2,237,401
Interest payable	25,593	277,003
Net cash provided by (used in) operating activities	(66,196,484)	(71,410,847)
Cash flows from investing activities
Purchase of plant, property, and equipment	(97,483)	(63,610)
Change in construction in process		16,215
Net cash provided by (used in) investing activities	(97,483)	(47,395)
Cash flows from financing activities
Proceeds from the sale of common stock	10,252,000	8,270,000
Proceeds from loans	3,537,500	3,640,000
Repayment of loans	(3,537,500)	(4,557,280)
Repayment of convertible notes	(1,100,735)
Advance from related party	600,000	409,230
Net cash provided by (used in) financing activities	9,751,265	7,761,950
Effect of exchange rate change on cash and cash equivalents	(3,782,324)	(14,849,542)
Net increase (decrease) in cash and cash equivalents	(60,325,026)	(78,545,834)
Cash and cash equivalents, beginning balance	72,259,804	150,805,639
Cash and cash equivalents, ending balance	11,934,778	72,259,804
Interest expense paid	304,071	318,122
Income taxes paid	2,889,673	5,129,686
Supplement non-cash activities
Common stock issued to repay accrued expense	330,000	240,500
Convertible notes payments	6,863,250
Nonmonetary sales and purchases	$ 43,537,582	$ 134,655,878